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Introduction
The identification of compounds with a desired biological activity is a key step in the drug discovery process. There is a growing need for efficient methods, capable of reliably identifying compounds in a relatively short time span with desired binding affinity.
Several NMR-based screening methods have been developed using chemical shift perturbation, [1] [2] [3] transferred NOE 4, 5 and diffusion and relaxation editing methods. [6] [7] [8] In the development of NMR techniques for measuring binding affinity, one of the main aims is the reduction of experiment time and of sample usage without isotope enrichment. Although a high resolution structure of protein-ligand complex is preferable in rational drug design, the mapping of specific interaction sites obtained by NMR techniques often provides valuable insights for identifying lead compounds or analyzing their mode of binding.
In designing NMR-based screening methods, it is critical to develop the technique capable of screening a large pool of new drug candidates and capable of identifying lead compounds with high affinity towards the target proteins. The most straightforward way to achieve this is by detecting only ligand signals while suppressing signals from target proteins. Recently, it has been shown that diffusion-based NOE-pumping experiment [9] [10] [11] can effectively be used to directly detect ligands that bind to the macromolecules. One of the disadvantages in this method is the technical difficulty to quickly optimize a diffusion filter for suppressing the ligand signals at a short NOE mixing time in preparation of the acquisition. For aim of developing an efficient and practical screening method to identify a lead compound with high affinity towards the protein receptor, a simple approach using the difference NOE-pumping experiment is implemented in this study.
Besides NMR spectroscopy, mass spectrometry has played an important role in library screening for determining the bound molecule either by MALDI-TOF 12 or ESI-MS. 13 Recently CSI-MS, a variant of ESI-MS operating at low temperature, was developed. 14, 15 It facilitates observation of weaker associations among proteins, since the temperature at the spray interface is much lower. Although ESI-MS has been used for the detection of non-covalent macromolecular associations, [16] [17] [18] [19] it is shown that CSI-MS is more sensitive in observations of macromolecular interaction. CSI-MS was successfully used to observe hyper-stranded DNA molecules that were unable to be detected by the ESI method 20 indicating the significant advance to detect non-covalent complexes in the biological systems. This paper presents an efficient solution-based approach using the difference NOE-pumping NMR technique and CSI-MS for the rapid and reliable screening in drug lead discovery. The efficiency of these techniques for identifying binding ligands is demonstrated with the human serum albumin (HSA)-drug system. The importance of serum albumin in anesthetic pharmacology derives from its high abundance in the circulatory system and from its capability of transporting fatty acids and binding a variety of metabolites and drugs, including most anesthetics. In some cases, more than 50% of a clinically administered general anesthetic could bind to serum albumin. The crystal structure of HSA reveals that it is heart-shaped and highly helical, consisting of three homologous domains (I, II and III). 21 Two primary drug binding sites are located in subdomains IIA and IIIA. Domain III possesses high affinity for small anionic aromatic compounds and is the primary binding site for medium-long chain fatty acids. In this study, salicylic acid, furosemide and warfarin were selected as the binding ligands which possess moderate affinity (Ka ∼10 5 M -1 ).
Experimental

NMR spectroscopy
All NMR experiments were performed on a JEOL Lamda-600 spectrometer. All of the spectra were recorded using 0.1 mM HSA and 10 mM salicylic acid, furosemide or warfarin in 99.9% 2 H2O containing 200 mM dimethylformamide at 25˚C. HSA (fatty acid-free) was purchased from Sigma, and salicylic acid, furosemide and warfarin were purchased from Wako (Osaka, Japan).
Cold-spray ionization mass spectrometry
CSI-MS measurements were performed using a double-focus (BE) mass spectrometer (JEOL JMS-700) equipped with a CSI source. An orthogonal cold-spray apparatus equipped with a spray-and ion-source temperature control system using liquid N2 was used. The spectra were obtained via infusion of HSAdrug complex through the cold-spray interface in positive ionization mode. Typical measurement conditions and sample preparation procedures are as follows: acceleration voltage 5.0 kV, needle voltage 2.3 kV, orifice voltage 240 V, ring voltage 278 V, resolution 1000, spray temperature 8˚C, sample flow rate 1.0 mL/h, 0.1 mM HSA and 1.0 mM salicylic acid, furosemide or warfarin dissolved in 10 mM NH4OAc (pH 7.5).
Results and Discussion
In the NOE-pumping pulse sequence (Fig. 1) , a diffusion filter is first applied to prepare a state in which small ligands are filtered out, while the protein signals are conserved. During the NOE mixing time (τm), the magnetization is transferred from macromolecule to the binding ligand and the protein signals become greatly attenuated. Consequently, only signals from binding ligands can be detected. Since magnetization can be transferred to the binding ligand in the free state, signals from the binding ligand (average of free and bound) can still be detected even if the bound ligand signal is too broad to be detected directly. This technique can be applied to very large proteins which show very broad NMR signals. The sensitivity of the NOE-pumping experiment increases with the molecular weight of the receptor, since the polarization transfer rates are directly proportional to the correlation time in the slow-motion limit.
The NOE-pumping and its difference spectra are shown in Figs. 2 -4 . In preparation for acquiring spectra, parameters for the diffusion filter have to be optimized. In short, the amplitude and duration of the gradient pulses and the diffusion time need to be optimized to suppress all ligand signals at a short NOE mixing time (∼5 ms). This optimization was successful in the complex of HSA-salicylic acid ( Fig. 2A) , while suppression of ligand signals was not satisfactory in furosemide and warfarin (Figs. 3A and 4A ). Affinity constants (Ka) for albumin binding of salicylic acid, 22 furosemide 23 and warfarin 22 are 2.2 × 10 5 M -1 , 1.7 × 10 5 M -1 and 1.5 × 10 5 M -1 , respectively, these indicate that the difficulty of suppressing ligand signals at a short NOE mixing time cannot be attributed to difference of affinities.
In the HSA-salicylic acid complex, NOE signals are observed for the H3/5 (6.85 ppm), H4 (7.34 ppm) and H6 (7.73 ppm) protons of salicylic acid (Figs. 2B and 2C) , as previously reported. 9 Because suppression of the ligand signals at short NOE mixing time (5 ms) was successful ( Fig. 2A) , it was not necessary to generate the difference spectrum to clarify the enhancement of NOE signals in this complex. In the HSAfurosemide complex, a diffusion filter to suppress the 1468 ANALYTICAL SCIENCES OCTOBER 2004, VOL. 20 Fig. 1 Pulse sequence of the NOE-pumping experiment. The thin and thick bars represent 90 degree and 180 degree pulses, respectively. All pulses were along x unless otherwise shown. Phases are φ1 = x, -x; φ2 = 2x, 2y, 2(-x), 2(-y); φ3 = 2x, 2y, 2(-x), 2(-y), 2(-x), 2(-y), 2x, 2y; φ4 = 16x, 16y, 16(-x), 16(-y); φr = 2(x, -x, -x, x), 2(-x, x, x, -x), 2(y, -y, -y, y), 2(-y, y, y, -y), 2(-x, x, x, -x), 2(x, -x, -x, x), 2(-y, y, y, -y), 2(y, -y, -y, y). All of the spectra were recorded using 10 mM drug (i.e., salicylic acid, furosemide or warfarin) and 0.1 mM HSA in 99.9% 2 H2O containing 200 mM dimethylformamide at 25˚C on a JEOL Lamda-600 spectrometer. The experimental parameters were: τ, 3.5 ms; T, 50 ms; NOE mixing (τm), 5 or 500 ms; G, 30.0 g/cm; spectral width, 6502 Hz; data size, 32768; number of transients per increment, 2048. Subtraction to obtain the difference spectra was performed using the JEOL software. Fig. 2 The difference NOE-pumping spectra of 0.1 mM HSA and 10 mM salicylic acid: (A) NOE-pumping spectrum acquired at τm = 5 ms; (B) NOE-pumping spectrum acquired at τm = 500 ms; (C) difference NOE-pumping spectrum for τm = 500 ms subtracted from τm = 5 ms; (D) 1D 1 H NMR spectrum.
Asterisks denote intermolecular NOEs. furosemide signals at short mixing time (5 ms) was not effective for the signals resonating at 6.87, 7.32 and 8.23 ppm (Fig. 3A) . Intermolecular NOE signals were clearly observed for all phenyl and furanyl protons in the difference spectrum (Fig. 3C) , although slight phase distortion was observed for the signal resonating at 8.23 ppm due to the imperfection of subtraction. In the HSA-warfarin complex, suppression of warfarin signals was not sufficient and the unsuppressed signals resonating between 7.0 -7.4 ppm were observed (Fig. 4A) . However, the enhanced NOE signals were clearly identified in the difference spectrum without considering the unsuppressed ligand signals (Fig. 4C) , which is the practical advantage of this method.
The CSI mass spectra of HSA bound with each drug at a spray temperature of 8˚C are shown in Fig. 5 . Under these conditions, HSA in the absence of drugs generated envelopes of ions between m/z 3936 and 4774, corresponding to 17+ through 14+ charge states (Fig. 5A) . The 16+ ion peak showing the highest intensity yielded a mass of 66859 Da. Similarly, HSA bound with each drug generated envelopes of ions between m/z 3700 and 4900 (Figs. 5B -5D ). The highest ion peak (16+ or 15+) in each complex yielded masses of 67197, 67930 or 67778 Da for the complex with salicylic acid (m.w. 138), furosemide (m.w. 331) or warfarin (m.w. 308), respectively. The differences of the calculated mass between the complex and HSA alone indicate that 2.4, 3.2 and 3.0 molecules of each drug (aforesaid order) are bound to HSA. The binding of drugs to HSA was studied by equilibrium dialysis and related methods, revealing one to three high-affinity binding sites for salicylic acid and one to two high-affinity sites for warfarin. 22, 24, 25 The recent study by equilibrium dialysis indicated that the apparent stoichiometry of salicylic acid binding was 3.2 ± 0.10. 26 The numbers of drugs bound to HSA obtained by CSI-MS measurements show a good agreement with that obtained by the past studies.
In conclusion, the difference NOE-pumping and CSI-MS experiments can easily provide valuable information of the complex, which is of great significance for characterizing the potential lead compounds. MS measurements at low solution temperature are favorable for observing the association of biomolecules in physiological conditions. These techniques are highly amenable to the high-throughput experiments used for determining binding affinity in the drug discovery process. 1469 ANALYTICAL SCIENCES OCTOBER 2004, VOL. 20 Fig. 3 The difference NOE-pumping spectra of 0.1 mM HSA and 10 mM furosemide: (A) NOE-pumping spectrum acquired at τm = 5 ms; (B) NOE-pumping spectrum acquired at τm = 500 ms; (C) difference NOE-pumping spectrum for τm = 500 ms subtracted from τm = 5 ms; (D) 1D 1 H NMR spectrum. Asterisks denote intermolecular NOEs. Fig. 4 The difference NOE-pumping spectra of 0.1 mM HSA and 10 mM warfarin: (A) NOE-pumping spectrum acquired at τm = 5 ms; (B) NOE-pumping spectrum acquired at τm = 500 ms; (C) difference NOE-pumping spectrum for τm = 500 ms subtracted from τm = 5 ms; (D) 1D 1 H NMR spectrum. Asterisks denote intermolecular NOEs. 
